Lv2
120 积分 2024-01-01 加入
HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractory (R/R) Settings
1个月前
已关闭
Dotting Out AML by Targeting Fibrillarin
5个月前
已完结
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
6个月前
已完结
Can the presence of aortic or coronary artery calcifications in the standard of care baseline CT or PET-CT scan of patients with Hodgkin or non-Hodgkin lymphoma be used as a predictor of MACE?
6个月前
已完结
Enhancing Prognostication and Treatment Response Evaluation in Primary CNS Lymphoma with 18F-FDG PET/CT
6个月前
已完结
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
7个月前
已完结
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
7个月前
已完结
Mitochondria at the crossroads of health and disease
7个月前
已完结
Multiple Myeloma Derived Mitochondrial Damps Induce Inflammation in the Bone Marrow Adipose Tissue Which Promotes Tumour Development
9个月前
已关闭
Multiple Myeloma Derived Mitochondrial Damps Induce Inflammation in the Bone Marrow Adipose Tissue Which Promotes Tumour Development
9个月前
已关闭
皖公网安备34019202002308
